Cyclotek, Australia’s leading radiopharmaceutical CDMO, is proud to announce its successful
read MoreCyclotek is excited to announce a contract development and manufacturing agreement with Radio
read MoreRadiopharmaceutical manufacturer Cyclotek and the University of Melbourne have signed
read MoreCyclotek is collaborating with Whitten Foundation-led research to pave the way for better det
read MoreIn collaboration with Macquarie University and Life Molecular Imaging (LMI), Cyclotek is plea
read MoreImmune-responsive cells of the brain – namely microglia and astrocytes – activate in resp
read More[contact-form-7 id=”714″ title=”Update Form”]